Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer
For patients with prostate cancer, the presence of a PMN is associated with increased rates of genomic testing overall, including among Black patients and other groups that experience health inequities. Utilization post-PMN was significantly lower in Black patients compared with non-Black patients. More research is needed into why Black patients show lower rates of genomic testing.
Authors
- A. J. Allen (ORCID: https://orcid.org/0009-0000-2863-5233)
- Taofeek K. Owonikoko (ORCID: https://orcid.org/0000-0002-7724-7728)
- Jason K. Molitoris (ORCID: https://orcid.org/0000-0002-8221-1631)
- Zaker Hamid Rana (ORCID: https://orcid.org/0000-0002-3409-2965)
- C. Eggleston
- Mark Vikas Mishra (ORCID: https://orcid.org/0000-0002-2588-1575)
- Zachery Keepers (ORCID: https://orcid.org/0009-0008-8730-5435)
- Jack J. Hong
- Matthew J. Ferris (ORCID: https://orcid.org/0000-0003-0402-4707)
- Bansi Savla (ORCID: https://orcid.org/0000-0001-8273-0725)
- W. Citron
- Dan Kunaprayoon
- R Benda (ORCID: https://orcid.org/0000-0002-0683-2102)
- Akshar N. Patel
- Melissa A.L. Vyfhuis (ORCID: https://orcid.org/0000-0003-4612-7341)
- W REGINE
- Claudia Datnow-Martinez (ORCID: https://orcid.org/0000-0002-2435-4992)
- Young Kwok
- William Silva Mendes
- Kaysee Baker
- Elai Davicioni
- Stefan Ambs
- Sophia C. Kamran
- Soren M. Bentzen
- Phuoc T. Tran
Institutions
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Massachusetts General Hospital (US)
- Veracyte (United States) (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- U-M Rogel Cancer Center (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1200/op-25-00983
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00